01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
On September 26, 2019, Justice Saliann Scarpulla of the New York State Supreme Court, County of New ...
Read More >
The Rhode Island Superior Court came down with a few interesting decisions this year concerning Rhod...
Read More >
One of the biggest problems for my clients after they hire me is that they realize that they never b...
Read More >
I have discussed in the past how the use of “no-rehire” provisions in settlement agreements betwee...
Read More >
As we wrote in a previous On the Subject, the Ninth Circuit Court of Appeals had signaled that it mi...
Read More >
The Architecture Billings Index (ABI) is a composite index derived from monthly report surveys from ...
Read More >